The once-daily pill also helped 75 per cent of patients who received the highest dose of orforglipron lower their A1C level - ...

An experimental GLP-1 pill has helped overweight adults with type 2 diabetes shed 10.5 per cent of body weight in a ...

Key Takeaways Eli Lilly reported a late-stage study of its oral weight-loss pill met primary and key secondary endpoints.The ...

Lilly announces positive trial results for its pill form GLP-1 medication, paving the way for global regulatory approval this ...

The results of the ATTAIN-2 study, which involved people with obesity or overweight and type 2 diabetes, showed that the oral ...

Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...

The TV presenter, 58, shared her concerns for 'impressionable young women' and said the endorsement was a 'betrayal of ...

(Reuters) -Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of ...

Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5pc of body weight in a late-stage trial, after recent data from another study of the drug ...

After Eli Lilly’s phase 3 data drop for its oral GLP-1 asset orforglipron earlier this month, the Indianapolis drugmaker has unveiled the second half of the data package that will support the med’s | ...

The system, which requires a monthly membership, can be used alone or with or after weight loss treatments such as GLP-1 ...